| NCT07008469 | Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 | ENROLLING_BY_INVITATION | PHASE3 | 2025-07-25 | 2030-10 | 2030-08 |
| NCT07038200 | A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | RECRUITING | PHASE3 | 2025-06-10 | 2028-07 | 2028-05 |
| NCT06547216 | Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD) | ENROLLING_BY_INVITATION | PHASE2 | 2024-07-25 | 2028-04 | 2028-04 |
| NCT06411288 | Global Study of Del-desiran for the Treatment of DM1 | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-05-30 | 2026-09 | 2026-03 |
| NCT06244082 | Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-01-22 | 2027-07-31 | 2027-04-30 |
| NCT05747924 | Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2023-04-04 | 2027-04 | 2026-10 |
| NCT05670730 | Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping | COMPLETED | PHASE1, PHASE2 | 2022-11-09 | 2024-11-25 | 2024-11-25 |
| NCT05479981 | Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients | COMPLETED | PHASE2 | 2022-08-04 | 2025-09-10 | 2025-09-05 |
| NCT05027269 | Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients | COMPLETED | PHASE1, PHASE2 | 2021-10-28 | 2023-02-14 | 2023-02-14 |